Advanced in Large-Cell Immunoblastic Lymphoma

Anne G. Crijns

Groningen, GR, NL 
Advanced in Large-Cell Immunoblastic Lymphoma
Groningen, GR, NL 
OverviewLocationsClinical Research

Overview

Anne Crijns practices in Groningen, Netherlands. Ms. Crijns is rated as an Advanced expert by MediFind in the treatment of Large-Cell Immunoblastic Lymphoma. Her top areas of expertise are Heart Tumor, Large-Cell Immunoblastic Lymphoma, Breast Cancer, Angioimmunoblastic T-cell Lymphoma, and Mastectomy.

Her clinical research consists of co-authoring 22 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Large-Cell Immunoblastic Lymphoma.

Gender
Female

Locations

Groningen, GR, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Early Detection of Cardiovascular Changes After Radiotherapy for Breast Cancer (EARLY HEART Study) in the Frame of the Implications of MEDIcal Low Dose RADiation Exposure (MEDIRAD) European Project
Early Detection of Cardiovascular Changes After Radiotherapy for Breast Cancer (EARLY HEART Study) in the Frame of the Implications of MEDIcal Low Dose RADiation Exposure (MEDIRAD) European Project
Enrollment Status: Completed
Publish Date: November 07, 2023
Intervention Type: Other
Study Phase: Not Applicable

22 Total Publications

Predicting acute coronary events after breast cancer radiotherapy: Integrating baseline cardiovascular risk, systemic therapy, and cardiac radiation dose in the MEDIRAD BRACE study.
Predicting acute coronary events after breast cancer radiotherapy: Integrating baseline cardiovascular risk, systemic therapy, and cardiac radiation dose in the MEDIRAD BRACE study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Crijns's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile